Is APOTEEK still active?

Yes, APOTEEK is currently active.

Where is APOTEEK registered?

APOTEEK's registered address is Meesberg 26, 3220 Holsbeek, Belgium.

Did APOTEEK make a profit or a loss?

APOTEEK's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €287,338.

When did APOTEEK last file annual accounts?

APOTEEK's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is APOTEEK B Corp certified?

We have no B Corp certification on file for APOTEEK.

Does APOTEEK hold Fairtrade certification?

No, APOTEEK does not currently hold Fairtrade certification.

APOTEEK

Q: When was APOTEEK founded?

APOTEEK was founded on 20 Dec 1989, making it 36 years old.

Q: What does APOTEEK do?

APOTEEK's registered main activities are Retail sale of pharmaceutical products, Retail sale of other food n.e.c., and Retail sale of drugstore products and cleaning materials.

BE 0439.657.151

Copied!

NV/SA

Status

Active

Founded

20 Dec 1989 · 36 yrs

Size

Small

Legal name

ARIMYLYSS

Main activity

Retail sale of pharmaceutical products

Activities

3 activities

Retail sale of pharmaceutical productsRetail sale of other food n.e.c.Retail sale of drugstore products and cleaning materials

Financials

Profit / Loss2025

€287K+127.8%

Equity2025

€4.6M+6.6%

Cash2025

€548K-6.4%

2025	2024	2023	2022
€287,338+127.8%	-€1,033,167-281.1%	€570,507+194.5%	€193,739
€4,635,046+6.6%	€4,347,708-19.2%	€5,380,875+11.9%	€4,810,368
€1,028,065+0.5%	€1,023,364>1000%	€30,561-1.8%	€31,132
€548,206-6.4%	€585,717-49.6%	€1,162,307+4.1%	€1,116,725

Frequently asked questions

01What is APOTEEK's official registered name?

ARIMYLYSS.

02What is APOTEEK's enterprise number (VAT number)?

BE 0439.657.151.

03What is APOTEEK's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was APOTEEK founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	-€14,936+79.6%	-€73,327<-1000%	-€6,221-29.6%	-€4,800
	€145,271-92.1%	€1,835,498	—	—
	-€64,742+78.3%	-€298,185<-1000%	-€7,181-26.7%	-€5,668
	€287,338+127.8%	-€1,033,167-281.1%	€570,507+194.5%	€193,739
	€5,370	—	€7,459-9.7%	€8,261
Profitability
	6.2%+126.1%	-23.8%-324.1%	10.6%+163.3%	4.0%
	5.0%+126.4%	-19.0%-282.5%	10.4%+163.9%	3.9%
Solvency
	€5,738,180+5.3%	€5,448,675-0.7%	€5,489,732+11.6%	€4,919,797
	€1,712,554+6.2%	€1,612,597	—	—
	€4,635,046+6.6%	€4,347,708-19.2%	€5,380,875+11.9%	€4,810,368
	80.8%+1.2%	79.8%-18.6%	98.0%+0.3%	97.8%
	€1,000,0000%	€1,000,000	—	—
	0.22-6.2%	0.23	—	—
	€1,028,065+0.5%	€1,023,364>1000%	€30,561-1.8%	€31,132
	0.22-5.8%	0.24>1000%	0.01-12.2%	0.01
Liquidity
	€548,206-6.4%	€585,717-49.6%	€1,162,307+4.1%	€1,116,725
	—	—	€159	—
	€216-39.4%	€357	—	€144
	€25,908+25.2%	€20,698-25.5%	€27,800-3.3%	€28,746
	123.90-10.9%	139.12-1.7%	141.60+15.9%	122.16
	€3,997,561+4.9%	€3,812,714-30.2%	€5,459,171+11.7%	€4,888,664
Profit appropriation
	€4,573,046+6.7%	€4,285,708-19.4%	€5,318,875+12%	€4,748,368